TCF12 overexpression as a poor prognostic factor in ovarian cancer
ConclusionThe results suggest that TCF12 is a poor prognostic factor of ovarian cancer and that targeting TCF12 may be a new therapeutic strategy for ovarian cancer treatment.
Source: Pathology Research and Practice - Category: Pathology Source Type: research
More News: Cancer | Cancer & Oncology | Molecular Biology | Ovarian Cancer | Ovaries | Pathology | Study